(0.91%) 5 064.20 points
(0.85%) 38 226 points
(1.51%) 15 841 points
(0.08%) $79.06
(5.02%) $2.03
(0.10%) $2 313.40
(0.68%) $26.93
(0.85%) $963.00
(-0.06%) $0.932
(-0.22%) $11.01
(-0.05%) $0.798
(-2.29%) $91.12
5 days till quarter result
(amc 2024-05-07)
Expected move: +/- 3.97%
Live Chart Being Loaded With Signals
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands...
Stats | |
---|---|
Šios dienos apimtis | 328 317 |
Vidutinė apimtis | 358 419 |
Rinkos kapitalizacija | 7.99B |
EPS | $0 ( 2024-02-22 ) |
Kita pelno data | ( $0.420 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 88.82 |
ATR14 | $0.230 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Roberts Johanna | Sell | 193 | Common Stock |
2024-04-01 | Roberts Johanna | Sell | 220 | Common Stock |
2024-04-01 | Roberts Johanna | Sell | 233 | Common Stock |
2024-04-01 | Roberts Johanna | Sell | 109 | Common Stock |
2024-04-01 | Roberts Johanna | Sell | 24 | Common Stock |
INSIDER POWER |
---|
-30.58 |
Last 100 transactions |
Buy: 40 001 | Sell: 77 662 |
Tūris Koreliacija
Penumbra Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
DMYS | 0.964 |
TMHC | 0.959 |
LEN-B | 0.958 |
BMAC | 0.957 |
CNDB | 0.956 |
PSPC | 0.956 |
EOCW | 0.955 |
NVR | 0.954 |
MTH | 0.954 |
CXAC | 0.954 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
PAK | -0.946 |
NYC | -0.945 |
RKLY | -0.944 |
EVTL | -0.937 |
DBMF | -0.935 |
TPL | -0.934 |
UNG | -0.932 |
GAZ | -0.932 |
VET | -0.93 |
ADM | -0.929 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Penumbra Inc Koreliacija - Valiuta/Žaliavos
Penumbra Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $1.06B |
Bruto pelnas: | $682.64M (64.49 %) |
EPS: | $2.37 |
FY | 2023 |
Pajamos: | $1.06B |
Bruto pelnas: | $682.64M (64.49 %) |
EPS: | $2.37 |
FY | 2022 |
Pajamos: | $847.13M |
Bruto pelnas: | $535.21M (63.18 %) |
EPS: | $-0.0529 |
FY | 2021 |
Pajamos: | $747.59M |
Bruto pelnas: | $475.38M (63.59 %) |
EPS: | $0.0716 |
Financial Reports:
No articles found.
Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.